carbamazepine has been researched along with Exanthema in 59 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Exanthema: Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to evaluate the safety and efficacy of extended release carbamazepine (CBZ-ER) monotherapy in the treatment of pediatric bipolar disorder (BD)." | 9.14 | A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder. ( Aleardi, M; Biederman, J; Doyle, R; Georgiopoulos, A; Hammerness, P; Joshi, G; Kotarski, M; Mick, E; Walls, S; Williams, C; Wozniak, J, 2010) |
| " Carbamazepine (CBZ) is widely used in MS to control pain." | 7.78 | Comparison of carbamazepine rash in multiple sclerosis and epilepsy. ( Alvestad, S; Brodtkorb, E; Espeset, K; Hovdal, H; Lydersen, S; Shirzadi, M, 2012) |
| "We describe the association of the HLA-B*1502 allele in 27 epilepsy patients (19 Malays, 8 Chinese) treated with carbamazepine (CBZ) at the UKM Medical Center (UKMMC), 6 with CBZ-Steven Johnson Syndrome (CBZ-SJS), 11 with CBZ-induced rash, 2 with suspected phenytoin-induced rash and 8 negative controls." | 7.77 | Frequency of the HLA-B*1502 allele contributing to carbamazepine-induced hypersensitivity reactions in a cohort of Malaysian epilepsy patients. ( Jamal, R; Rani, ZZ; Ratnaningrum, S; Raymond, AA; Then, SM, 2011) |
| " Two patients presented severe febrile skin eruption following drug intake (carbamazepine or sulfazalazine), with hypereosinophilia and hepatitis." | 7.71 | [DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) syndrome after sulfasalazine and carmazepine: report of two cases]. ( Catteau, B; Delcey, V; Devulder, B; Fauchais, AL; Hachulla, E; Hatron, PY; Launay, D; Legout, L; Michon-Pasturel, U; Queyrel, V, 2001) |
| "Detection of DRESS syndrome is dependent on the exclusion of a variety of diseases with similar manifestations and may be delayed in time." | 6.44 | Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review. ( Baldaranov, I; Gancheva, T; Ganeva, M; Hristakieva, E; Lazarova, R; Troeva, J; Tzaneva, V; Vassilev, I, 2008) |
| "Carbamazepine is a widely used drug." | 6.43 | Carbamazepine-induced acute liver failure as part of the DRESS syndrome. ( Holt, AP; Mutimer, DJ; Naisbitt, DJ; Pirmohamed, M; Syn, WK, 2005) |
| "DRESS syndrome is a multisystem disorder that appears in the context of an adverse drug reaction, characterized by fever, rash and peripheral eosinophilia with involvement of other organs such as the liver." | 5.91 | DRESS syndrome secondary to carbamazepine. ( Almohalla-Álvarez, C; Alonso-Martín, C; García-Pajares, F; González López, A; Martín Guerra, JM; Miramontes-González, JP; Morejón Huerta, B; Moreta Rodríguez, M, 2023) |
| "Acute generalised exanthematous pustulosis and Stevens-Johnson syndrome (toxic epidermal necrolysis spectrum of severe cutaneous drug reactions) are believed to have distinct underlying pathophysiologies." | 5.35 | Acute generalised exanthematous pustulosis and toxic epidermal necrolysis induced by carbamazepine. ( Goh, SG; Goh, TK; Pang, SM; Thirumoorthy, T, 2008) |
| "DRESS syndrome is well described in adults treated with aromatic anti-epileptic drugs, such as phenytoin, phenobarbital, and carbamazepine, but also with other drugs." | 5.32 | [Oxcarbazepine and DRESS syndrome: a paediatric cause of acute liver failure]. ( Bosdure, E; Boyer, M; Cano, A; Reynaud, R; Roquelaure, B; Sarles, J; Viard, L, 2004) |
| "Generalised acute exanthematic pustuloses are severe skin reactions that are induced by drugs." | 5.30 | [Generalized acute exanthematous pustulosis caused by carbamazepine]. ( Lachgar, T, 1999) |
| "The aim of this study was to evaluate the safety and efficacy of extended release carbamazepine (CBZ-ER) monotherapy in the treatment of pediatric bipolar disorder (BD)." | 5.14 | A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder. ( Aleardi, M; Biederman, J; Doyle, R; Georgiopoulos, A; Hammerness, P; Joshi, G; Kotarski, M; Mick, E; Walls, S; Williams, C; Wozniak, J, 2010) |
| "Oxcarbazepine and its primary metabolite have been effective in animal models of epilepsy that generally predict efficacy in generalized tonic-clonic seizures and partial seizures in humans." | 4.81 | Oxcarbazepine, an antiepileptic agent. ( Huff, NA; Kalis, MM, 2001) |
| "The antiepileptic drug hypersensitivity syndrome (AHS) is an adverse drug reaction associated with the aromatic antiepileptic drugs (AEDs) phenytoin (PHT), carbamazepine (CBZ), phenobarbital (PB), and primidone." | 4.80 | Antiepileptic drug hypersensitivity syndrome. ( Schlienger, RG; Shear, NH, 1998) |
| " Carbamazepine- or oxcarbazepine-induced maculopapular exanthema occurred earlier (median: one week) than that induced by other antiseizure medications (median: three weeks) (p=0." | 4.02 | Cutaneous adverse reactions associated with antiseizure medication: clinical characteristics and implications in epilepsy treatment. ( Bettinotti, MP; Braatz, VL; de Paola, L; Iglehart, B; Lohr, A; Rodrigues, M; Silvado, CES; Tensini, FS; Tensini, TS; Von Glehn, CQC, 2021) |
| "Increasing studies reported genetic susceptibility to drug hypersensitivity reactions, as exemplified by the HLA-A*31:01 and HLA-B*15:02 association with carbamazepine (CBZ)-induced hypersensitivity reactions, such as maculopapular exanthema (MPE), drug rash with eosinophilia and systemic symptoms (DRESS), and Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN)." | 3.80 | Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations. ( Chang, PY; Chang, WC; Chang, YG; Chen, DP; Chen, MJ; Chung, WH; Ho, HC; Hsiao, YH; Hsih, MS; Hui, RC; Hung, SI; Lin, JY; Wu, T; Wu, TL; Yang, CH, 2014) |
| "We enrolled 19 patients with epilepsy who had discontinued oxcarbazepine because of skin rash despite an initial good response and then became refractory to other antiepileptic drugs along with an individual with paroxysmal kinesigenic dyskinesia with a similar situation." | 3.80 | Human leukocyte antigen genotypes and trial of desensitization in patients with oxcarbazepine-induced skin rash: a pilot study. ( Kang, ES; Lee, B; Lee, J; Lee, M; Yu, HJ, 2014) |
| " Carbamazepine (CBZ) is widely used in MS to control pain." | 3.78 | Comparison of carbamazepine rash in multiple sclerosis and epilepsy. ( Alvestad, S; Brodtkorb, E; Espeset, K; Hovdal, H; Lydersen, S; Shirzadi, M, 2012) |
| "We describe the association of the HLA-B*1502 allele in 27 epilepsy patients (19 Malays, 8 Chinese) treated with carbamazepine (CBZ) at the UKM Medical Center (UKMMC), 6 with CBZ-Steven Johnson Syndrome (CBZ-SJS), 11 with CBZ-induced rash, 2 with suspected phenytoin-induced rash and 8 negative controls." | 3.77 | Frequency of the HLA-B*1502 allele contributing to carbamazepine-induced hypersensitivity reactions in a cohort of Malaysian epilepsy patients. ( Jamal, R; Rani, ZZ; Ratnaningrum, S; Raymond, AA; Then, SM, 2011) |
| " All had dermatological manifestations, eosinophilia and systemic (haematological and hepatic) manifestations that could be attributed to treatment with aromatic AEDs (carbamazepine, 2 patients; lamotrigine, 3 patients; phenytoin, 3 patients)." | 3.77 | Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs. ( Kochen, S; Pereira de Silva, N; Piquioni, P; Saidon, P, 2011) |
| "Carbamazepine causes various forms of hypersensitivity reactions, ranging from maculopapular exanthema to severe blistering reactions." | 3.77 | HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. ( Alfirevic, A; Alhusaini, S; Bourgeois, S; Carrington, M; Cavalleri, GL; Chaila, E; Chinthapalli, K; de Bakker, PI; Delanty, N; Deloukas, P; Depondt, C; Farrell, JJ; Goldstein, DB; Heinzen, EL; Jia, X; Johnson, MR; Kasperavičiūtė, D; Marson, T; McCormack, M; Molokhia, M; O'Connor, GD; Pandolfo, M; Park, BK; Pichler, W; Pirmohamed, M; Radtke, RA; Shianna, KV; Sills, GJ; Sisodiya, SM; Walley, N, 2011) |
| "The anticonvulsant carbamazepine (CBZ) frequently causes cutaneous adverse drug reactions (cADRs), including maculopapular eruption (MPE), hypersensitivity syndrome (HSS), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)." | 3.73 | Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. ( Chang, YT; Chen, GS; Chen, WC; Chen, WH; Chen, YT; Chung, WH; Fang, WH; Hsiao, PF; Hu, SL; Huang, YL; Hung, SI; Jee, SH; Lee, WR; Lin, JJ; Lou, YH; Shih, HY; Wei, CY; Wong, TW; Wu, MT, 2006) |
| " Two patients presented severe febrile skin eruption following drug intake (carbamazepine or sulfazalazine), with hypereosinophilia and hepatitis." | 3.71 | [DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) syndrome after sulfasalazine and carmazepine: report of two cases]. ( Catteau, B; Delcey, V; Devulder, B; Fauchais, AL; Hachulla, E; Hatron, PY; Launay, D; Legout, L; Michon-Pasturel, U; Queyrel, V, 2001) |
| "We report two cases of concomitant rashes and blood dyscrasias in geriatric psychiatry patients receiving carbamazepine therapy for bipolar disorder." | 3.70 | Concomitant rash and blood dyscrasias in geriatric psychiatry patients treated with carbamazepine. ( Cates, M; Powers, R, 1998) |
| "The first patient was a 47-year-old man who developed fever, lymphadenopathy, influenza-like symptoms, facial edema, skin rash and diarrhea after 3 weeks of carbamazepine (CBZ) treatment." | 3.70 | Colitis may be part of the antiepileptic drug hypersensitivity syndrome. ( Dofferhoff, AS; Eland, IA; Stricker, BH; Vink, R; Zondervan, PE, 1999) |
| "Carbamazepine or phenytoin was withdrawn over the next 4 weeks; then patients entered a 12-week monotherapy period." | 2.69 | An active-control trial of lamotrigine monotherapy for partial seizures. ( Chang, GY; Gilliam, F; Messenheimer, J; Nyberg, J; Risner, ME; Rudd, GD; Sackellares, JC; Vazquez, B, 1998) |
| "Oxcarbazepine is a new antiepileptic drug." | 2.52 | [Adverse effects of oxcarbazepine]. ( Fang, S; Gong, ZC, 2015) |
| "Detection of DRESS syndrome is dependent on the exclusion of a variety of diseases with similar manifestations and may be delayed in time." | 2.44 | Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review. ( Baldaranov, I; Gancheva, T; Ganeva, M; Hristakieva, E; Lazarova, R; Troeva, J; Tzaneva, V; Vassilev, I, 2008) |
| "Carbamazepine is a widely used drug." | 2.43 | Carbamazepine-induced acute liver failure as part of the DRESS syndrome. ( Holt, AP; Mutimer, DJ; Naisbitt, DJ; Pirmohamed, M; Syn, WK, 2005) |
| "DRESS syndrome is a multisystem disorder that appears in the context of an adverse drug reaction, characterized by fever, rash and peripheral eosinophilia with involvement of other organs such as the liver." | 1.91 | DRESS syndrome secondary to carbamazepine. ( Almohalla-Álvarez, C; Alonso-Martín, C; García-Pajares, F; González López, A; Martín Guerra, JM; Miramontes-González, JP; Morejón Huerta, B; Moreta Rodríguez, M, 2023) |
| "Lithium carbonate was associated with increased risks of rash (PT), drug interaction (PT), and tubulointerstitial diseases (SMQ)." | 1.72 | Analysis of adverse drug events in patients with bipolar disorders using the Japanese Adverse Drug Event Report database. ( Nabekura, T; Uwai, Y, 2022) |
| "Maculopapular exanthema and delayed-appearing urticaria were the most reported hypersensitivity reactions to AEDs." | 1.51 | Hypersensitivity reactions to antiepileptic drugs in children. ( Atanasković-Marković, M; Ćirković Veličković, T; Gavrović-Jankulović, M; Janković, J; Nikolić, D; Škorić, D; Tmušić, V, 2019) |
| "We report a case of maculopapular skin rash due to LEV with cross-sensitivity with CBZ which has not been reported till date." | 1.51 | Cross-sensitivity of Levetiracetam and Carbamazepine Induced Skin Rash. ( Panda, S, 2019) |
| "Carbamazepine was and still used extensively in clinical practice in varied indications can cause adverse drug reaction shaving diverse clinical manifestations of variable severity." | 1.51 | DRESS Syndrome. ( Garg, S; Jain, P; Maheshwari, S; Sharma, VK, 2019) |
| "Eslicarbazepine is a new anti-epileptic drug, chemically related to carbamazepine but with a more favorable safety profile." | 1.48 | Patch testing in a case of eslicarbazepine and carbamazepine induced cutaneous reaction. ( Custódio, P; Finelli, E; Leiria-Pinto, P; Porovska, O; Prates, S, 2018) |
| "Eslicarbazepine acetate (ESL) is an anticonvulsant drug approved for the treatment of focal epilepsies, and related to oxcarbazepine and carbamazepine (CBZ), which are also derivatives of the dibenzazepine family." | 1.46 | Eslicarbazepine acetate as a therapeutic option in a patient with carbamazepine-induced rash and HLA-A*31:01. ( Kay, L; Klein, KM; Reif, PS; Rosenow, F; Strzelczyk, A; Willems, LM; Zöllner, JP, 2017) |
| "DRESS syndrome is usually underdiagnosed and has a good response to systemic steroids." | 1.42 | [DRESS syndrome: Report of nine cases]. ( Barbosa-Moreno, LE; Guerrero-González, GA; Martínez-Villarreal, JD; Ocampo-Candiani, J; Ocampo-Garza, J; Ocampo-Garza, SS, 2015) |
| "The histopathology of DRESS syndrome highlights various associated inflammatory patterns in a single biopsy." | 1.42 | Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study. ( Bastuji-Garin, S; Chosidow, O; de Feraudy, S; Delfau-Larue, MH; Duong, TA; Ortonne, N; Roujeau, JC; Valeyrie-Allanore, L; Wechsler, J; Wolkenstein, P, 2015) |
| "Because DRESS syndrome is potentially life threatening, it is especially important to diagnose it early." | 1.39 | Pediatrician! Do you know the symptoms of DRESS syndrome? A case report of a 4-year-old girl. ( Adamkiewicz-Drozynska, E; Irga, N; Jaworski, R; Kosiak, W; Zielinski, J, 2013) |
| "Acute generalised exanthematous pustulosis and Stevens-Johnson syndrome (toxic epidermal necrolysis spectrum of severe cutaneous drug reactions) are believed to have distinct underlying pathophysiologies." | 1.35 | Acute generalised exanthematous pustulosis and toxic epidermal necrolysis induced by carbamazepine. ( Goh, SG; Goh, TK; Pang, SM; Thirumoorthy, T, 2008) |
| "DRESS syndrome is well described in adults treated with aromatic anti-epileptic drugs, such as phenytoin, phenobarbital, and carbamazepine, but also with other drugs." | 1.32 | [Oxcarbazepine and DRESS syndrome: a paediatric cause of acute liver failure]. ( Bosdure, E; Boyer, M; Cano, A; Reynaud, R; Roquelaure, B; Sarles, J; Viard, L, 2004) |
| "Generalised acute exanthematic pustuloses are severe skin reactions that are induced by drugs." | 1.30 | [Generalized acute exanthematous pustulosis caused by carbamazepine]. ( Lachgar, T, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (6.78) | 18.7374 |
| 1990's | 8 (13.56) | 18.2507 |
| 2000's | 13 (22.03) | 29.6817 |
| 2010's | 29 (49.15) | 24.3611 |
| 2020's | 5 (8.47) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JW | 1 |
| Lee, SR | 1 |
| Kim, MJ | 1 |
| Cho, S | 1 |
| Youn, SW | 1 |
| Yang, MS | 1 |
| Kim, SH | 1 |
| Kang, HR | 1 |
| Kwon, O | 1 |
| Min, F | 1 |
| Fan, C | 1 |
| Zeng, Y | 1 |
| He, N | 1 |
| Zeng, T | 1 |
| Qin, B | 1 |
| Shi, Y | 1 |
| Moreta Rodríguez, M | 1 |
| García-Pajares, F | 1 |
| Almohalla-Álvarez, C | 1 |
| Alonso-Martín, C | 1 |
| González López, A | 1 |
| Miramontes-González, JP | 1 |
| Martín Guerra, JM | 1 |
| Morejón Huerta, B | 1 |
| Uwai, Y | 1 |
| Nabekura, T | 1 |
| Sanoria, A | 1 |
| Arora, R | 1 |
| Dokania, P | 1 |
| Tensini, TS | 1 |
| Von Glehn, CQC | 1 |
| Bettinotti, MP | 1 |
| Iglehart, B | 1 |
| de Paola, L | 1 |
| Lohr, A | 1 |
| Rodrigues, M | 1 |
| Tensini, FS | 1 |
| Braatz, VL | 1 |
| Silvado, CES | 1 |
| Kay, L | 1 |
| Willems, LM | 1 |
| Zöllner, JP | 1 |
| Reif, PS | 1 |
| Klein, KM | 1 |
| Rosenow, F | 1 |
| Strzelczyk, A | 1 |
| Marín, JA | 2 |
| Ortega, MA | 1 |
| Sánchez, IP | 1 |
| Pacheco, JA | 1 |
| Ros, MM | 1 |
| Delsing, CE | 1 |
| Puerto-Fuentes, A | 1 |
| Ortiz-Martínez, YS | 1 |
| Finelli, E | 1 |
| Custódio, P | 1 |
| Porovska, O | 1 |
| Prates, S | 1 |
| Leiria-Pinto, P | 1 |
| Salloum, S | 1 |
| Lane, A | 1 |
| Atanasković-Marković, M | 1 |
| Janković, J | 1 |
| Tmušić, V | 1 |
| Gavrović-Jankulović, M | 1 |
| Ćirković Veličković, T | 1 |
| Nikolić, D | 1 |
| Škorić, D | 1 |
| Jain, P | 1 |
| Garg, S | 1 |
| Sharma, VK | 1 |
| Maheshwari, S | 1 |
| Panda, S | 1 |
| Irga, N | 1 |
| Kosiak, W | 1 |
| Jaworski, R | 1 |
| Zielinski, J | 1 |
| Adamkiewicz-Drozynska, E | 1 |
| Hsiao, YH | 1 |
| Hui, RC | 1 |
| Wu, T | 1 |
| Chang, WC | 1 |
| Hsih, MS | 1 |
| Yang, CH | 2 |
| Ho, HC | 2 |
| Chang, YG | 1 |
| Chen, MJ | 1 |
| Lin, JY | 1 |
| Chen, DP | 1 |
| Chang, PY | 1 |
| Wu, TL | 1 |
| Hung, SI | 4 |
| Chung, WH | 4 |
| Toh, DS | 1 |
| Tan, LL | 1 |
| Aw, DC | 1 |
| Pang, SM | 2 |
| Lim, SH | 1 |
| Thirumoorthy, T | 2 |
| Lee, HY | 1 |
| Tay, YK | 1 |
| Tan, SK | 1 |
| Vasudevan, A | 1 |
| Lateef, A | 1 |
| Chong, YY | 1 |
| Chan, YC | 1 |
| Loke, C | 1 |
| Chan, CL | 1 |
| Koay, ES | 1 |
| Ren, EC | 1 |
| Lee, EJ | 1 |
| Sung, C | 1 |
| Lee, B | 1 |
| Yu, HJ | 1 |
| Kang, ES | 1 |
| Lee, M | 1 |
| Lee, J | 1 |
| Ortonne, N | 1 |
| Valeyrie-Allanore, L | 1 |
| Bastuji-Garin, S | 1 |
| Wechsler, J | 1 |
| de Feraudy, S | 1 |
| Duong, TA | 1 |
| Delfau-Larue, MH | 1 |
| Chosidow, O | 1 |
| Wolkenstein, P | 1 |
| Roujeau, JC | 1 |
| Fang, S | 1 |
| Gong, ZC | 1 |
| Ocampo-Garza, J | 1 |
| Ocampo-Garza, SS | 1 |
| Martínez-Villarreal, JD | 1 |
| Barbosa-Moreno, LE | 1 |
| Guerrero-González, GA | 1 |
| Ocampo-Candiani, J | 1 |
| Goh, TK | 1 |
| Goh, SG | 1 |
| Chiou, CC | 1 |
| Yang, LC | 1 |
| Chang, YC | 1 |
| Kuo, TT | 1 |
| Hu, S | 1 |
| Hong, HS | 1 |
| Ganeva, M | 1 |
| Gancheva, T | 1 |
| Lazarova, R | 1 |
| Troeva, J | 1 |
| Baldaranov, I | 1 |
| Vassilev, I | 1 |
| Hristakieva, E | 1 |
| Tzaneva, V | 1 |
| Joshi, G | 1 |
| Wozniak, J | 1 |
| Mick, E | 1 |
| Doyle, R | 1 |
| Hammerness, P | 1 |
| Georgiopoulos, A | 1 |
| Kotarski, M | 1 |
| Aleardi, M | 1 |
| Williams, C | 1 |
| Walls, S | 1 |
| Biederman, J | 1 |
| Maschio, M | 1 |
| Dinapoli, L | 1 |
| Vidiri, A | 1 |
| Muti, P | 1 |
| Ben Fredj, N | 1 |
| Aouam, K | 2 |
| Chaabane, A | 2 |
| Toumi, A | 1 |
| Ben Rhomdhane, F | 1 |
| Boughattas, N | 1 |
| Chakroun, M | 1 |
| Wang, XQ | 1 |
| Lang, SY | 1 |
| Shi, XB | 1 |
| Tian, HJ | 1 |
| Wang, RF | 1 |
| Yang, F | 1 |
| Pereira de Silva, N | 1 |
| Piquioni, P | 1 |
| Kochen, S | 1 |
| Saidon, P | 1 |
| McCormack, M | 1 |
| Alfirevic, A | 1 |
| Bourgeois, S | 1 |
| Farrell, JJ | 1 |
| Kasperavičiūtė, D | 1 |
| Carrington, M | 1 |
| Sills, GJ | 1 |
| Marson, T | 1 |
| Jia, X | 1 |
| de Bakker, PI | 1 |
| Chinthapalli, K | 1 |
| Molokhia, M | 1 |
| Johnson, MR | 1 |
| O'Connor, GD | 1 |
| Chaila, E | 1 |
| Alhusaini, S | 1 |
| Shianna, KV | 1 |
| Radtke, RA | 1 |
| Heinzen, EL | 1 |
| Walley, N | 1 |
| Pandolfo, M | 1 |
| Pichler, W | 1 |
| Park, BK | 1 |
| Depondt, C | 1 |
| Sisodiya, SM | 1 |
| Goldstein, DB | 1 |
| Deloukas, P | 1 |
| Delanty, N | 1 |
| Cavalleri, GL | 1 |
| Pirmohamed, M | 2 |
| Chauhan, A | 1 |
| Anand, S | 1 |
| Thomas, S | 1 |
| Subramanya, HC | 1 |
| Pradhan, G | 1 |
| Shirzadi, M | 1 |
| Alvestad, S | 1 |
| Hovdal, H | 1 |
| Espeset, K | 1 |
| Lydersen, S | 1 |
| Brodtkorb, E | 1 |
| Daly, AK | 1 |
| Then, SM | 1 |
| Rani, ZZ | 1 |
| Raymond, AA | 1 |
| Ratnaningrum, S | 1 |
| Jamal, R | 1 |
| Yang, CY | 1 |
| Dao, RL | 1 |
| Lee, TJ | 1 |
| Lu, CW | 1 |
| Khaled, A | 1 |
| Souissi, A | 1 |
| Zeglaoui, F | 1 |
| El Fekih, N | 1 |
| Daghfous, R | 1 |
| Fazaa, B | 1 |
| Valencak, J | 1 |
| Ortiz-Urda, S | 1 |
| Heere-Ress, E | 1 |
| Kunstfeld, R | 1 |
| Base, W | 1 |
| Marsden, D | 1 |
| Libretto, SE | 1 |
| Bosdure, E | 1 |
| Cano, A | 1 |
| Roquelaure, B | 1 |
| Reynaud, R | 1 |
| Boyer, M | 1 |
| Viard, L | 1 |
| Sarles, J | 1 |
| Syn, WK | 1 |
| Naisbitt, DJ | 1 |
| Holt, AP | 1 |
| Mutimer, DJ | 1 |
| Jee, SH | 1 |
| Chen, WC | 1 |
| Chang, YT | 1 |
| Lee, WR | 1 |
| Hu, SL | 1 |
| Wu, MT | 1 |
| Chen, GS | 1 |
| Wong, TW | 1 |
| Hsiao, PF | 1 |
| Chen, WH | 1 |
| Shih, HY | 1 |
| Fang, WH | 1 |
| Wei, CY | 1 |
| Lou, YH | 1 |
| Huang, YL | 1 |
| Lin, JJ | 1 |
| Chen, YT | 1 |
| Obermoser, G | 1 |
| Zelger, B | 1 |
| Balatsinou, C | 1 |
| Milano, A | 1 |
| Laterza, F | 1 |
| Caldarella, MP | 1 |
| Angelucci, D | 1 |
| Vecchiet, J | 1 |
| Zingariello, P | 1 |
| Falasca, K | 1 |
| Lapenna, D | 1 |
| Neri, M | 1 |
| Livingston, S | 1 |
| Pauli, LL | 1 |
| Berman, W | 1 |
| Bel Hadj Ali, H | 1 |
| Youssef, M | 1 |
| Amri, M | 1 |
| Boughattas, NA | 1 |
| Zili, JE | 1 |
| Alanko, K | 1 |
| Madrigal Díez, V | 1 |
| Alonso Palacio, J | 1 |
| Arteaga Manjón-Cabeza, R | 1 |
| Herranz Fernández, JL | 1 |
| Cates, M | 1 |
| Powers, R | 1 |
| Gilliam, F | 1 |
| Vazquez, B | 1 |
| Sackellares, JC | 1 |
| Chang, GY | 1 |
| Messenheimer, J | 1 |
| Nyberg, J | 1 |
| Risner, ME | 1 |
| Rudd, GD | 1 |
| Schlienger, RG | 1 |
| Shear, NH | 1 |
| Lachgar, T | 1 |
| Eland, IA | 1 |
| Dofferhoff, AS | 1 |
| Vink, R | 1 |
| Zondervan, PE | 1 |
| Stricker, BH | 1 |
| Balasubramanian, S | 1 |
| Shobhana, S | 1 |
| Padmasani, LN | 1 |
| Natarajan, M | 1 |
| Rao, R | 1 |
| Kalis, MM | 1 |
| Huff, NA | 1 |
| Queyrel, V | 1 |
| Catteau, B | 1 |
| Michon-Pasturel, U | 1 |
| Fauchais, AL | 1 |
| Delcey, V | 1 |
| Launay, D | 1 |
| Legout, L | 1 |
| Hachulla, E | 1 |
| Hatron, PY | 1 |
| Devulder, B | 1 |
| Lalla, M | 1 |
| Virolainen, M | 1 |
| Rasmussen, P | 1 |
| Riishede, J | 1 |
| Steen-Johnsen, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The BrainDrugs-Epilepsy Study: A Prospective Open-label Cohort Precision Medicine Study in Epilepsy[NCT05450822] | 550 participants (Anticipated) | Observational | 2022-02-18 | Recruiting | |||
| A Preliminary Study of the Efficacy and Safety of Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency[NCT01379469] | Phase 2 | 20 participants (Actual) | Interventional | 2012-01-31 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for carbamazepine and Exanthema
| Article | Year |
|---|---|
[Adverse effects of oxcarbazepine].
Topics: Anticonvulsants; Carbamazepine; Exanthema; Humans; Hyponatremia; Oxcarbazepine | 2015 |
Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review.
Topics: Adult; Anticonvulsants; Biopsy, Needle; Carbamazepine; Drug Eruptions; Eosinophilia; Exanthema; Fema | 2008 |
Using genome-wide association studies to identify genes important in serious adverse drug reactions.
Topics: Aryl Hydrocarbon Hydroxylases; Carbamazepine; Chemical and Drug Induced Liver Injury; Cytochrome P-4 | 2012 |
Carbamazepine-induced acute liver failure as part of the DRESS syndrome.
Topics: Adult; Anticonvulsants; Carbamazepine; Chemical and Drug Induced Liver Injury, Chronic; Drug Eruptio | 2005 |
Antiepileptic drug hypersensitivity syndrome.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cross Reactions; Diagnosis, Differential; D | 1998 |
Oxcarbazepine, an antiepileptic agent.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Interactions; | 2001 |
3 trials available for carbamazepine and Exanthema
| Article | Year |
|---|---|
A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder.
Topics: Antimanic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Body Weight; Carb | 2010 |
An active-control trial of lamotrigine monotherapy for partial seizures.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Double-Blind Method; Epilepsies, Partial; E | 1998 |
Facial pain treated with carbamazepin (Tegretol).
Topics: Adult; Age Factors; Aged; Carbamazepine; Clinical Trials as Topic; Dibenzazepines; Exanthema; Facial | 1970 |
50 other studies available for carbamazepine and Exanthema
| Article | Year |
|---|---|
Skin manifestations and clinical features of drug reaction with eosinophilia and systemic symptoms: a retrospective multicentre study of 125 patients.
Topics: Carbamazepine; Drug Hypersensitivity Syndrome; Eosinophilia; Exanthema; Humans; Retrospective Studie | 2022 |
Carbamazepine-modified HLA-A*24:02-bound peptidome: Implication of CORO1A in skin rash.
Topics: Anticonvulsants; Carbamazepine; Drug Hypersensitivity; Exanthema; Genetic Predisposition to Disease; | 2022 |
DRESS syndrome secondary to carbamazepine.
Topics: Anticonvulsants; Benzodiazepines; Carbamazepine; Drug Hypersensitivity Syndrome; Eosinophilia; Exant | 2023 |
Analysis of adverse drug events in patients with bipolar disorders using the Japanese Adverse Drug Event Report database.
Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug | 2022 |
Bilateral acute angle closure as presenting feature of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS).
Topics: Acute Disease; Adult; Anterior Eye Segment; Anticonvulsants; Carbamazepine; Drug Hypersensitivity Sy | 2019 |
Cutaneous adverse reactions associated with antiseizure medication: clinical characteristics and implications in epilepsy treatment.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Exanthema; Humans; Oxcarbazepine; Stevens-Johnson Syndrome | 2021 |
Eslicarbazepine acetate as a therapeutic option in a patient with carbamazepine-induced rash and HLA-A*31:01.
Topics: Adult; Anticonvulsants; Carbamazepine; Dibenzazepines; Epilepsy, Frontal Lobe; Exanthema; Female; Ha | 2017 |
[Drug rash with eosinophilia and systemic symptoms syndrome induced by carbamazepine: Case report].
Topics: Anticonvulsants; Carbamazepine; Drug Eruptions; Eosinophilia; Exanthema; Fever; Humans; Male; Syndro | 2017 |
[A woman with fever and a rash].
Topics: Anticonvulsants; Carbamazepine; Eosinophilia; Exanthema; Female; Fever; Humans; Liver; Middle Aged | 2017 |
Letter to the editor "Drug rash with eosinophilia and systemic symptoms syndrome induced by carbamazepine: Case report".
Topics: Carbamazepine; Drug Eruptions; Eosinophilia; Exanthema; Humans | 2017 |
Patch testing in a case of eslicarbazepine and carbamazepine induced cutaneous reaction.
Topics: Allergens; Anticonvulsants; Carbamazepine; Dibenzazepines; Disease Progression; Drug Hypersensitivit | 2018 |
Case 2: A 13-year-old Boy with a Perplexing Rash.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Diagnosis, Differential; Drug Hypersensitivity Syndrome; | 2019 |
Hypersensitivity reactions to antiepileptic drugs in children.
Topics: Adolescent; Allergens; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Diagnosis, Different | 2019 |
DRESS Syndrome.
Topics: Carbamazepine; Drug Hypersensitivity Syndrome; Eosinophilia; Exanthema; Fever; Humans | 2019 |
Cross-sensitivity of Levetiracetam and Carbamazepine Induced Skin Rash.
Topics: Anticonvulsants; Carbamazepine; Drug Hypersensitivity Syndrome; Exanthema; Humans; Levetiracetam | 2019 |
Pediatrician! Do you know the symptoms of DRESS syndrome? A case report of a 4-year-old girl.
Topics: Anticonvulsants; Carbamazepine; Child, Preschool; Diagnosis, Differential; Drug Hypersensitivity; Eo | 2013 |
Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Child; China; Cohort Stu | 2014 |
Building pharmacogenetics into a pharmacovigilance program in Singapore: using serious skin rash as a pilot study.
Topics: Adult; Alleles; Carbamazepine; Case-Control Studies; Exanthema; Genotype; HLA-B Antigens; Humans; Mi | 2014 |
Human leukocyte antigen genotypes and trial of desensitization in patients with oxcarbazepine-induced skin rash: a pilot study.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Desensitization, Immunologic; D | 2014 |
Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Anti-Bacterial Agents; B-Lymphocytes; Carba | 2015 |
[DRESS syndrome: Report of nine cases].
Topics: Adolescent; Adult; Aged; Carbamazepine; Dexamethasone; Drug Hypersensitivity Syndrome; Eosinophilia; | 2015 |
Acute generalised exanthematous pustulosis and toxic epidermal necrolysis induced by carbamazepine.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Eruptions; Exanthema; Female; Humans; Skin Diseases, Ves | 2008 |
Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan.
Topics: Adolescent; Adult; Aged; Allopurinol; Carbamazepine; Eosinophilia; Exanthema; Female; Humans; Hydroc | 2008 |
Rash in four patients with brain tumor-related epilepsy in monotherapy with oxcarbazepine, during radiotherapy.
Topics: Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Carbamazepine; Combined Modality Therapy; C | 2010 |
Hypersensitivity to amoxicillin after drug rash with eosinophilia and systemic symptoms (DRESS) to carbamazepine and allopurinol: a possible co-sensitization.
Topics: Adult; Allopurinol; Amoxicillin; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Drug Hyperse | 2010 |
Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
Topics: Adolescent; Adult; Aged; Amines; Anticonvulsants; Carbamazepine; Chi-Square Distribution; Child; Chi | 2010 |
Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anticonvulsants; Carbamazepine; Disease Susceptibility; | 2011 |
HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.
Topics: Anticonvulsants; Carbamazepine; Drug Hypersensitivity; Exanthema; Genome-Wide Association Study; Gen | 2011 |
HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.
Topics: Anticonvulsants; Carbamazepine; Drug Hypersensitivity; Exanthema; Genome-Wide Association Study; Gen | 2011 |
HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.
Topics: Anticonvulsants; Carbamazepine; Drug Hypersensitivity; Exanthema; Genome-Wide Association Study; Gen | 2011 |
HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.
Topics: Anticonvulsants; Carbamazepine; Drug Hypersensitivity; Exanthema; Genome-Wide Association Study; Gen | 2011 |
Carbamazepine induced DRESS syndrome.
Topics: Adolescent; Anticonvulsants; Biopsy; Carbamazepine; Dermatitis, Exfoliative; Drug Eruptions; Drug Hy | 2010 |
Comparison of carbamazepine rash in multiple sclerosis and epilepsy.
Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Exanthema; Female; H | 2012 |
Frequency of the HLA-B*1502 allele contributing to carbamazepine-induced hypersensitivity reactions in a cohort of Malaysian epilepsy patients.
Topics: Adolescent; Adult; Alleles; Asian People; Carbamazepine; Child; Child, Preschool; Cohort Studies; Dr | 2011 |
Severe cutaneous adverse reactions to antiepileptic drugs in Asians.
Topics: Adult; Anticonvulsants; Asian People; Carbamazepine; Exanthema; Female; Follow-Up Studies; Humans; L | 2011 |
[DRESS syndrome].
Topics: Adolescent; Adult; Allopurinol; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti | 2012 |
Carbamazepine-induced DRESS syndrome with recurrent fever and exanthema.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Eruptions; Eosinophilia; Exanthema; Female; Fever; Human | 2004 |
Hypersensitivity to topiramate sprinkle capsules does not preclude the use of topiramate tablets.
Topics: Administration, Oral; Adolescent; Anticonvulsants; Benzodiazepines; Capsules; Carbamazepine; Clobaza | 2004 |
[Oxcarbazepine and DRESS syndrome: a paediatric cause of acute liver failure].
Topics: Acute Kidney Injury; Anticonvulsants; Carbamazepine; Child; Drug Eruptions; Eosinophilia; Exanthema; | 2004 |
Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.
Topics: Anticonvulsants; Carbamazepine; Case-Control Studies; Drug Hypersensitivity; Exanthema; Genetic Pred | 2006 |
Fever, eosinophilia, and a rash.
Topics: Adult; Antimanic Agents; Carbamazepine; Depressive Disorder; Diagnosis, Differential; Drug Eruptions | 2006 |
Esophagitis and anticonvulsant hypersensitivity syndrome.
Topics: Anticonvulsants; Carbamazepine; Deglutition Disorders; Drug Hypersensitivity; Endoscopy, Gastrointes | 2006 |
Carbamazepine (Tegretol) in epilepsy. Nine year follow-up study with special emphasis on untoward reactions.
Topics: Adolescent; Adult; Alkaline Phosphatase; Anticonvulsants; Carbamazepine; Child; Diplopia; Drug Overd | 1974 |
Carbamazepine-induced DRESS and HHV6 primary infection: the importance of skin tests.
Topics: Adult; Anticonvulsants; Carbamazepine; Eosinophilia; Epilepsy; Exanthema; Exanthema Subitum; Hematol | 2008 |
Patch testing in cutaneous reactions caused by carbamazepine.
Topics: Adolescent; Adult; Aged; Carbamazepine; Dermatitis, Exfoliative; Drug Eruptions; Erythema Multiforme | 1993 |
[Carbamazepine: serious intolerance in interstitial pneumonia, fever, exanthema and immunoglobulin deficiency].
Topics: Carbamazepine; Child, Preschool; Drug Hypersensitivity; Epilepsies, Partial; Exanthema; Female; Feve | 1993 |
Concomitant rash and blood dyscrasias in geriatric psychiatry patients treated with carbamazepine.
Topics: Aged; Antimanic Agents; Bipolar Disorder; Carbamazepine; Exanthema; Female; Humans; Male; Paraprotei | 1998 |
[Generalized acute exanthematous pustulosis caused by carbamazepine].
Topics: Anticonvulsants; Antimanic Agents; Carbamazepine; Drug Eruptions; Exanthema; Female; Humans; Middle | 1999 |
Colitis may be part of the antiepileptic drug hypersensitivity syndrome.
Topics: Adult; Anticonvulsants; Carbamazepine; Colitis; Drug Hypersensitivity; Epilepsies, Partial; Epilepsy | 1999 |
Carbamazepine hypersensitivity syndrome.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Conjunctivitis, Allergic; Drug Eruptions; Drug Hypersens | 1999 |
[DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) syndrome after sulfasalazine and carmazepine: report of two cases].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants | 2001 |
Blood lymphoblast proliferation in vivo in cutaneous drug hypersensitivity reactions.
Topics: Blood Cell Count; Carbamazepine; Chlorpromazine; Drug Hypersensitivity; Exanthema; Humans; Lymphocyt | 1974 |
[Severe reactions with the use of carbamazepine (Tegretol)].
Topics: Carbamazepine; Child; Dibenzazepines; Eosinophilia; Exanthema; Female; Humans; Serum Sickness; Time | 1970 |